Literature DB >> 16493611

Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization.

Bipin N Savani, Cynthia E Dunbar, Margaret E Rick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16493611     DOI： 10.1002/ajh.20506

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

Review 1.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

Review 2.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.